Interestingly, a recent clinical trial indicated that BTK inhibition decreases disease flares in multiple sclerosis patients [5], but the evidence for the role of BTK in autoimmune and inflammatory disorders is sporadic [6]. The gene discussed is BTK; the disease is multiple sclerosis.